These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7060027)

  • 1. Blood levels of a pteridine-binding alpha 1-acid glycoprotein in cancer patients.
    Fink M; Ziegler I; Maier K; Wilmanns W
    Cancer Res; 1982 Apr; 42(4):1574-8. PubMed ID: 7060027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pteridine-binding alpha 1-acid glycoprotein from blood of patients with neoplastic diseases.
    Ziegler I; Maier K; Fink M
    Cancer Res; 1982 Apr; 42(4):1567-73. PubMed ID: 7060026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias.
    Patel PS; Adhvaryu SG; Balar DB; Parikh BJ; Shah PM
    Anticancer Res; 1994; 14(2B):747-51. PubMed ID: 8010734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the levels of phenylalanine, tyrosine and tetrahydrobiopterin in the blood of tumor-bearing organisms.
    Kokolis N; Ziegler I
    Cancer Biochem Biophys; 1977; 2(2):79-85. PubMed ID: 616325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pteridine formation during lectin-induced lymphocyte activation.
    Ziegler I
    J Cell Biochem; 1985; 28(3):197-206. PubMed ID: 4066775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopterin level in peripheral blood cells as a marker for hemopoietic cell proliferation during leukemia and polycythemia vera.
    Ziegler I; Fink M; Wilmanns W
    Blut; 1982 Apr; 44(4):231-40. PubMed ID: 6952953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pteridines in patients with different tumors.
    Zeitler HJ; Andondonskaja-Renz B
    Cancer Detect Prev; 1987; 10(1-2):71-9. PubMed ID: 3568011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a radioimmunoassay for alpha 1-acid glycoprotein to monitor therapy of cancer patients.
    Ganz PA; Shell WE; Tökés ZA
    J Natl Cancer Inst; 1983 Jul; 71(1):25-30. PubMed ID: 6575206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
    Holladay JW; Dewey MJ; Michniak BB; Wiltshire H; Halberg DL; Weigl P; Liang Z; Halifax K; Lindup WE; Back DJ
    Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1 -acid glycoprotein and binding of basic drugs.
    Paxton JW
    Methods Find Exp Clin Pharmacol; 1983 Nov; 5(9):635-48. PubMed ID: 6366403
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of serum protein binding of felodipine.
    Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19-9 as a marker in the preoperative staging of colorectal cancer: a prospective clinical study.
    Yüceyar S; Ertürk S; Dirican A; Cengiz A; Saner H
    Int Surg; 1996; 81(2):136-9. PubMed ID: 8912078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of certain anti-tuberculosis drugs is affected by binding to alpha-1-acid glycoprotein.
    Johnson DA; Smith KD
    Biomed Chromatogr; 2006; 20(6-7):551-60. PubMed ID: 16779786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein.
    Kumar GN; Walle UK; Bhalla KN; Walle T
    Res Commun Chem Pathol Pharmacol; 1993 Jun; 80(3):337-44. PubMed ID: 8102493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional and subcellular distribution of biopterin in the rat.
    Hennings G; Rembold H
    Int J Vitam Nutr Res; 1982; 52(1):36-43. PubMed ID: 7085198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis.
    Hashimoto S; Asao T; Takahashi J; Yagihashi Y; Nishimura T; Saniabadi AR; Poland DC; van Dijk W; Kuwano H; Kochibe N; Yazawa S
    Cancer; 2004 Dec; 101(12):2825-36. PubMed ID: 15536618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1-acid glycoprotein and peripheral nerve injury, studied with a wound chamber.
    Liu HM; Lei HY; Schmid K
    Lab Invest; 1993 May; 68(5):577-83. PubMed ID: 7684476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum free and bound sialic acid and alpha-1-acid glycoprotein in patients with laryngeal cancer.
    Uslu C; Taysi S; Akcay F; Sutbeyaz MY; Bakan N
    Ann Clin Lab Sci; 2003; 33(2):156-9. PubMed ID: 12817619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcome.
    Le Coutre P; Kreuzer KA; Na IK; Schwarz M; Lupberger J; Holdhoff M; Baskaynak G; Gschaidmeier H; Platzbecker U; Ehninger G; Prejzner W; Huhn D; Schmidt CA
    Am J Hematol; 2003 Aug; 73(4):249-55. PubMed ID: 12879428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.